The global spirometry devices market accounted for USD 1.24 billion in 2023 and is expected to reach USD 3.62 billion by 2034 with a CAGR of 10.23% during the forecast period 2024-2034. The market will rise as a result of factors such as the rising prevalence of respiratory diseases, technological advancements, increased awareness of respiratory health, and favorable reimbursement policies.
The market for spirometry equipment is significantly driven by the rising prevalence of respiratory conditions such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). Spirometry devices are becoming more and more in demand for diagnosis, monitoring, and management of these illnesses as they continue to rise globally due to causes including smoking, pollution, and aging populations. For instance, in November 2022, Philips unveiled the EPIQ Elite ultrasound system, which offers sophisticated imaging features and AI-powered apps to improve diagnostic precision and workflow effectiveness across a range of medical specializations.
By type, the table-top spirometers segment accounted for the highest revenue-grossing segment in the global spirometry devices market in 2023 owing to the increasing adoption in clinical settings, where their accuracy and advanced features cater to the needs of healthcare professionals for comprehensive pulmonary function testing. For instance, Smiths Medical introduced the CADD®-Solis VIP ambulatory infusion pump in February 2023. This pump has improved safety features and connectivity options to ensure effective medicine delivery in both home and clinical settings. Additionally, the hand-held spirometers segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for portable and user-friendly devices, particularly for home monitoring and point-of-care testing, as well as advancements in technology making them more accurate, compact, and convenient for both patients and healthcare providers.
By technology, the volume measurement spirometers segment accounted for the highest revenue-grossing segment in the global spirometry devices market in 2023 owing to the increasing prevalence of respiratory diseases requiring precise and comprehensive measurement of lung function parameters, driving the demand for volume measurement spirometers due to their accuracy and reliability in clinical diagnosis and management. For instance, BD announced in June 2022 that it would acquire Velano Vascular, a company that specializes in cutting-edge blood-collecting technologies. Through this acquisition, BD's offering of vascular access solutions has increased. Additionally, the flow measurement spirometers segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing focus on monitoring airflow obstruction and dynamic lung function changes in conditions like asthma and COPD, spurring demand for flow measurement spirometers due to their ability to provide detailed airflow data for accurate diagnosis and treatment monitoring.
By application, the chronic obstructive pulmonary disease (COPD) segment accounted for the highest revenue-grossing segment in the global spirometry devices market in 2023 owing to the increasing prevalence of COPD worldwide, driving the demand for spirometry devices for diagnosis, monitoring, and management of this chronic respiratory condition. For instance, Hill-Rom Holdings announced in August 2022 that it was acquiring Bardy Diagnostics, Inc., a pioneer in ambulatory cardiac monitoring technologies. Additionally, the other applications segment is predicted to grow at the fastest CAGR during the forecast period owing to the expansion of spirometry device usage beyond traditional applications like asthma and COPD, encompassing emerging areas such as occupational lung diseases, cystic fibrosis, and preoperative assessments, reflecting a broader adoption across various healthcare domains.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global spirometry devices market in 2023 owing to the high patient footfall in clinical settings, where spirometry tests are routinely conducted for diagnosis, monitoring, and treatment evaluation of respiratory conditions, highlighting the significant demand for spirometry devices among healthcare facilities. For instance, Vyaire Medical expanded its line of respiratory care products for patients with sleep disorders in September 2022 with the introduction of the EnliteTM Vented Full Face Mask. Additionally, the home healthcare segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing preference for remote monitoring and self-management of chronic respiratory conditions, driving the demand for portable and user-friendly spirometry devices suitable for use in home healthcare settings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the robust healthcare infrastructure, high prevalence of respiratory diseases, favorable reimbursement policies, and early adoption of advanced spirometry technologies, driving significant market growth in the North American region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising awareness about respiratory health, increasing healthcare expenditure, expanding geriatric population, and improving healthcare infrastructure, fostering significant growth opportunities for spirometry device manufacturers in the Asia Pacific region. For instance, in August 2022, Midmark Corporation announced the acquisition of Intelligent Hospital Systems (IH Systems), a leader in automated pharmacy solutions, to improve medication administration capabilities across healthcare settings.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
The market for spirometry equipment is significantly driven by the rising prevalence of respiratory conditions such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). Spirometry devices are becoming more and more in demand for diagnosis, monitoring, and management of these illnesses as they continue to rise globally due to causes including smoking, pollution, and aging populations. For instance, in November 2022, Philips unveiled the EPIQ Elite ultrasound system, which offers sophisticated imaging features and AI-powered apps to improve diagnostic precision and workflow effectiveness across a range of medical specializations.
By type, the table-top spirometers segment accounted for the highest revenue-grossing segment in the global spirometry devices market in 2023 owing to the increasing adoption in clinical settings, where their accuracy and advanced features cater to the needs of healthcare professionals for comprehensive pulmonary function testing. For instance, Smiths Medical introduced the CADD®-Solis VIP ambulatory infusion pump in February 2023. This pump has improved safety features and connectivity options to ensure effective medicine delivery in both home and clinical settings. Additionally, the hand-held spirometers segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for portable and user-friendly devices, particularly for home monitoring and point-of-care testing, as well as advancements in technology making them more accurate, compact, and convenient for both patients and healthcare providers.
By technology, the volume measurement spirometers segment accounted for the highest revenue-grossing segment in the global spirometry devices market in 2023 owing to the increasing prevalence of respiratory diseases requiring precise and comprehensive measurement of lung function parameters, driving the demand for volume measurement spirometers due to their accuracy and reliability in clinical diagnosis and management. For instance, BD announced in June 2022 that it would acquire Velano Vascular, a company that specializes in cutting-edge blood-collecting technologies. Through this acquisition, BD's offering of vascular access solutions has increased. Additionally, the flow measurement spirometers segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing focus on monitoring airflow obstruction and dynamic lung function changes in conditions like asthma and COPD, spurring demand for flow measurement spirometers due to their ability to provide detailed airflow data for accurate diagnosis and treatment monitoring.
By application, the chronic obstructive pulmonary disease (COPD) segment accounted for the highest revenue-grossing segment in the global spirometry devices market in 2023 owing to the increasing prevalence of COPD worldwide, driving the demand for spirometry devices for diagnosis, monitoring, and management of this chronic respiratory condition. For instance, Hill-Rom Holdings announced in August 2022 that it was acquiring Bardy Diagnostics, Inc., a pioneer in ambulatory cardiac monitoring technologies. Additionally, the other applications segment is predicted to grow at the fastest CAGR during the forecast period owing to the expansion of spirometry device usage beyond traditional applications like asthma and COPD, encompassing emerging areas such as occupational lung diseases, cystic fibrosis, and preoperative assessments, reflecting a broader adoption across various healthcare domains.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global spirometry devices market in 2023 owing to the high patient footfall in clinical settings, where spirometry tests are routinely conducted for diagnosis, monitoring, and treatment evaluation of respiratory conditions, highlighting the significant demand for spirometry devices among healthcare facilities. For instance, Vyaire Medical expanded its line of respiratory care products for patients with sleep disorders in September 2022 with the introduction of the EnliteTM Vented Full Face Mask. Additionally, the home healthcare segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing preference for remote monitoring and self-management of chronic respiratory conditions, driving the demand for portable and user-friendly spirometry devices suitable for use in home healthcare settings.
North American region is anticipated to have the highest revenue share during the forecast period owing to the robust healthcare infrastructure, high prevalence of respiratory diseases, favorable reimbursement policies, and early adoption of advanced spirometry technologies, driving significant market growth in the North American region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising awareness about respiratory health, increasing healthcare expenditure, expanding geriatric population, and improving healthcare infrastructure, fostering significant growth opportunities for spirometry device manufacturers in the Asia Pacific region. For instance, in August 2022, Midmark Corporation announced the acquisition of Intelligent Hospital Systems (IH Systems), a leader in automated pharmacy solutions, to improve medication administration capabilities across healthcare settings.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Type, Technology, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Spirometry Devices Market Report 2023 - 2034
Spirometry Devices Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Hand-held Spirometers
- Table-top Spirometers
Spirometry Devices Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Volume Measurement Spirometers
- Flow Measurement Spirometers
Spirometry Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Other Applications
Spirometry Devices Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals and Clinics
- Home Healthcare
- Others
Spirometry Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Spirometry Devices Market: Type Estimates & Trend Analysis
8. Spirometry Devices Market: Technology Estimates & Trend Analysis
9. Spirometry Devices Market: Application Estimates & Trend Analysis
10. Spirometry Devices Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Spirometry Devices Market
13. Europe Global Spirometry Devices Market
14. Asia Pacific Global Spirometry Devices Market
15. Latin America Global Spirometry Devices Market
16. MEA Global Spirometry Devices Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- BD (Becton
- Dickinson and Company)
- Philips Healthcare
- Smiths Medical
- Hill-Rom Holdings Inc.
- Vyaire Medical
- Nihon Kohden Corporation
- Schiller AG
- MGC Diagnostics Corporation
- Vitalograph Ltd.
- Midmark Corporation
- COSMED
- SDI Diagnostics
- Fukuda Sangyo Co. Ltd.
- Morgan Scientific Inc.
